RSA Vs RCR for Massive RCTs
Treatment of Degenerative Massive Rotator Cuff Tears: a Multicenter, Randomized Comparative Surgical Trial
1 other identifier
interventional
160
2 countries
2
Brief Summary
Different treatment options are available for massive or irreparable rotator cuff tears. An arthroscopic or an open repair approach is possible in the majority of cases and functional outcomes are improved, particularly when a complete arthroscopic repair can be achieved. However, the healing rate of massive rotator cuff tears after repair may remain low and failure of healing is associated with progression of arthritis. An alternative to arthroscopic or open repair is reverse shoulder arthroplasty which decreases pain and improves function, active shoulder elevation and quality of life. The primary goal of this prospective multicentric randomized study is to determine if there is a difference of functional outcomes between rotator cuff repair (RCR) repair and reverse shoulder arthroplasty (RSA).
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Mar 2023
Longer than P75 for not_applicable
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2023
CompletedFirst Submitted
Initial submission to the registry
March 29, 2023
CompletedFirst Posted
Study publicly available on registry
April 11, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
March 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
March 1, 2027
October 26, 2024
October 1, 2024
4 years
March 29, 2023
October 23, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
American Shoulder and Elbow Surgeon (ASES) score
American Shoulder and Elbow Surgeon (ASES) score. From 0 (worst) to 100 (best).
At 24 post-operative months
Secondary Outcomes (15)
Pain on Visual Analogue Scale (pVAS)
At 24 post-operative months
Constant score
At 24 post-operative months
Single Assessment Numeric Evaluation (SANE)
At 24 post-operative months
Complication
Within the 24 post-operative months
Location of the defect
At 24 post-operative months
- +10 more secondary outcomes
Study Arms (2)
Arthroscopic surgery
ACTIVE COMPARATORThe massive degenerative rotator cuff tear are treated by arthroscopy. It consists in reattaching the torn tendon with anchors and sutures.
Reverse shoulder arthroplasty
EXPERIMENTALThe problems induced by the massive degenerative rotator cuff tear are solved by a complete replacement of the shoulder joint with a prosthesis (reverse design).
Interventions
The surgeon reattaches the torn tendon to the bone with anchors and sutures.
It consists in replacing the shoulder joint with a total shoulder prosthesis (reverse design).
Eligibility Criteria
You may qualify if:
- Patient voluntarily consents to participate
- Patient with a massive and reparable non traumatic rotator cuff tears after failure of conservative treatment
- Patients with the following pre-operative images: Three standardized X-rays series and Magnetic Resonance Imaging (MRI) or arthro Magnetic Resonance Imaging without sign of traumatic lesions
You may not qualify if:
- Patient has known intentions, obligations, or co-morbidity that would inhibit them from participating in the study
- Revision rotator cuff repair
- Patient consent withdrawal
- Glenohumeral arthritis defined as stage \> 3 Hamada classification
- Infection and neuropathic joints
- Known or suspected non-compliance, drug or alcohol abuse
- Patients incapable of judgement or under tutelage
- Inability to follow the procedures of the study
- Enrolment of the investigator, his/her family members, employees and other dependent persons
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- La Tour Hospitallead
Study Sites (2)
Oregon Health & Science University
Portland, Oregon, 97239, United States
La Tour hospital
Meyrin, Canton of Geneva, 1217, Switzerland
Related Publications (1)
Ladermann A, Pernoud A, Cochard B, Bothorel H. Treatment of degenerative massive rotator cuff tears: a study protocol for a randomized non-inferiority comparative surgical trial. Trials. 2025 Aug 4;26(1):270. doi: 10.1186/s13063-025-08990-9.
PMID: 40759980DERIVED
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Alexandre Lädermann, MD
La Tour hospital, Meyrin (1217) Geneva, Switzerland
- PRINCIPAL INVESTIGATOR
Patrick Denard, MD
Department of Orthopaedics and Rehabilitation, Oregon Health & Science University, Portland, OR, USA
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- The statistician will be blinded to patient allocation groups.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Orthopaedic Surgeon FMH, Shoulder and Elbow Surgery Traumatology
Study Record Dates
First Submitted
March 29, 2023
First Posted
April 11, 2023
Study Start
March 1, 2023
Primary Completion (Estimated)
March 1, 2027
Study Completion (Estimated)
March 1, 2027
Last Updated
October 26, 2024
Record last verified: 2024-10